Business news

ASX-listed pot stocks reviewed

So-called pot stocks have been popular on the ASX since the start of 2017, with a number seeing their share prices rocket up.

MGC Pharma ramps up EU cannabis operations

ASX-listed MGC Pharmaceuticals has moved nearly 500 marijuana plants to its growing facilities in the Czech Republic as it advances its European medicinal cannabis operations.

Cannabis Extracts: The next Canadian oil boom

Canada’s medical cannabis market began as a flower-only market, but, following a court ruling, the licensed producers (LPs) were permitted to begin producing extracts in late 2015.

Grupo Flor cannabis group is getting organized despite uncertainty

It would be easy to see the first ever cannabis sponsor of the three-year-old Forbes AgTech Summit as a sign that legal, commercial cannabis has finally arrived.

Epilepsy treatments head Bod Australia’s priorities

Bod Australia is looking to cash in on expected demand for cannabis-based treatments through plans to import an oil used to help children with epilepsy.

This medical marijuana start-up uses artificial intelligence to find which strain is best for you

Artificial intelligence is being used to improve banking, marketing, the legal field — and now to find which one of the more than 30,000 strains of medical marijuana is best for you.

Growing demand drives flurry of Aussie–Israeli cannabis partnerships

An Israeli company will partner with an Australian one to help boost clinical education opportunities around medical cannabis.

Chapmans investment in AZ Pharmaceuticals Inc facilitates entry into medicinal cannabis market

Diversified investment company focused on high-growth market segments, Chapmans (ASX: CHP) announced on Friday that its specialist wholly owned medicinal cannabis subsidiary, Cannabis Investments Limited (CIL), had entered into a Term Sheet with AZ Pharmaceuticals Inc.

Cannabis Science releases chronic pain transdermal patches

Cannabis Science, Inc., a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that its new product-development plans are well underway with the release of the first batch of the CBIS Transdermal Patch.